Optics.org
daily coverage of the optics & photonics industry and the markets that it serves
Featured Showcases
Photonex+Vacuum Technologies
News
Menu
Quidel's system could test for viruses such as Covid-19.
BARDA funding is to support the development of a point-of-care diagnostic assay that potentially tests for four respiratory viruses: SARS-CoV-2 (Covid-19), Influenza A, Influenza B, and Respiratory Syncytial Virus. The respiratory virus panel would be developed to run on Quidel’s Sofia 2 flagship instrument.

Copyright © 2021 SPIE EuropeDesigned by Kestrel Web Services